发明名称 |
ALLOGENEIC IMMUNE RESPONSE CONTROL |
摘要 |
The present invention relates in general to prevention, reduction or treatment of rejection in transplant patients. In particular the invention relates to the use of SSRIs (selective serotonin reuptake inhibitors) for the prevention, reduction or treatment of rejection in transplant patients, such as blood cell, stem cell, bone marrow, tissue or organ rejection. |
申请公布号 |
WO2013076245(A1) |
申请公布日期 |
2013.05.30 |
申请号 |
WO2012EP73466 |
申请日期 |
2012.11.23 |
申请人 |
UNIVERSITEIT GENT;ACADEMISCH MEDISCH CENTRUM |
发明人 |
DEFORCE, DIETER;DENYS, DAMIAAN;GOBIN, VEERLE;TILLEMAN, KELLY |
分类号 |
A61K31/135;A61K31/4525;C12N5/00 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|